Publication | Closed Access

Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice

Alzheimer's DiseaseMedicineDementiaCell DeathApp/ps1 Transgenic MiceErythrocyte Membrane-encapsulated CelecoxibNeuroprotectionNeuroscienceNeurologyCognitive DeclineCell BiologyNeuroinflammation